View Clinical Trial (Medical Research Study)

Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis - NCT00705159-16501(Clinical Trial 228925)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Erie
State:  
PA
Zip Code: 16501
Conditions: Blepharokeratoconjunctivitis
Purpose: The objective of this study is to evaluate the safety and effectiveness of Zylet in comparison with Lotemax, Tobramycin and the vehicle of Zylet for the treatment of blepharoconjunctivitis in pediatric subjects.
Study summary:
Criteria: Inclusion Criteria: - children 0-6 years of age. - clinical diagnosis of blepharoconjunctivitis - Parent/guardian must understand, be willing and able to comply with all treatment and follow-up procedures. - Parent/guardian must understand, be willing and able to provide informed consent and Health Insurance Portability Accountability Act (HIPAA) authorization. Exclusion Criteria: - Known hypersensitivity to corticosteroids, aminoglycosides, or any component of the study medication. - Subjects who have a history of ocular surgery, including laser procedures, within the past 6 months. - Subjects who are monocular. - Subjects who have a history of any severe/serious ocular pathology or medical condition that could result in the subject's inability to complete the study. - Subjects who have participated in an ophthalmic drug or device research study within 30 days prior to entry in this study.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 16, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.